SERINA SCHAMA: Open Payments
NPI 1457010175 · TOLEDO, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,458 in 174 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $1,394 · 2025 $3,458
Food & beverage: $3,346Education: $111
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 31 | $674 |
| Vanda Pharmaceuticals Inc. | 25 | $609 |
| Axsome Therapeutics, Inc. | 17 | $353 |
| ABBVIE INC. | 30 | $340 |
| Lundbeck LLC | 14 | $307 |
| Neurocrine BioSciences, Inc. | 12 | $258 |
| E.R. Squibb & Sons, L.L.C. | 12 | $193 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $188 |
| Indivior Inc. | 7 | $162 |
| Teva Pharmaceuticals USA, Inc. | 3 | $138 |
Products named: REXULTI, HETLIOZ, Auvelity, ABILIFY MAINTENA, VRAYLAR, INGREZZA, FANAPT, COBENFY.
Industry payments across OH — which companies pay providers there.
